As of March 2025 Revance Therapeutics has a market cap of €0.36 Billion. This makes Revance Therapeutics the world's 7248th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.